May 26, 2006
IVIG Supply Index represents FFF's aggregate inventory of all IVIG products for our customers who have established product allocations with us. Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.

Red represents 21 days supply or less, yellow is 22 to 29 days, green is 30 days supply or more.
From the CDC
MMWR Dispatch Update: Multistate Outbreak of Mumps — United States, January 1-May 2, 2006  LINK...

From Marketwatch.com
Novartis to build vaccine plant in U.S.  LINK...

From PharmaManufacturing.com
Inside GSK's New RFID Pilot  LINK...

From Talecris
Talecris Biotherapeutics Launches Talents: Talecris New Trials Support Program   LINK...

From Marketwatch.com
HHS Awards for $1 billion flu vaccine R&D  LINK...

From BioSpace
Phase 3 Study Results Of MedImmune, Inc. (MEDI)'s Next-Generation Influenza Vaccine Suggest Better Relative Efficacy Against Matched And Mismatched Strains Compared To The Flu Shot In Young Children  LINK...

From Sun-Sentinel.com
Legislation intensifies fears about counterfeit medication  LINK...

MyFluVaccine: Your Answer to Flu Season Uncertainty

On May 3, 2006, FFF Enterprises successfully launched MyFluVaccine, an extraordinary new program that resolves the uncertainty of your flu vaccine supply.

MyFluVaccine allows you to place your flu vaccine order online, easily schedule your delivery dates within a defined delivery season, and secure your order and delivery dates with a modest prepayment.

Customer input on the challenges of the traditional vaccine ordering system led to our development of MyFluVaccine, and their response to the new program has been gratifying. They've commented on the ease of ordering and the truly innovative nature of MyFluVaccine that brings certainty to the flu season for the first time.

Visit www.MyFluVaccine.com to secure your flu vaccine order, so you, too, can schedule vaccine clinics with certainty.

With MyFluVaccine, you pick the dates, you pick the quantities, and FFF delivers.

For more information, visit www.MyFluVaccine.com or call your FFF Sales Rep at 800-843-7477.











Take Action to Resolve the IVIG Shortage
If you are having trouble obtaining IVIG for your patients, the FDA needs to hear from you as soon as possible.

Please call 800-835-4709 or email your story to CBERProductShortages@cber.fda.gov.

Patients and healthcare providers across the country are reporting difficulties acquiring IVIG, and at least five patients have died as a direct result of lack of access to the product.

The FDA has indicated that there is not enough evidence to declare an IVIG shortage, so they cannot yet take action to resolve it. But you can help by letting the FDA know about your experience.

Again, if you are having trouble obtaining IVIG, please contact the FDA at once and share your story with them.

You can call 800-835-4709 or email your story to CBERProductShortages@cber.fda.gov.

Please contact the FDA today. Your story may help save lives.

Click here for more information.

BioSupply Trends is published by FFF Enterprises, the nation's most trusted distributor of biopharmaceuticals, plasma products and vaccines. FFF Enterprises is accelerating the availability of products, from development to delivery. Click here to contact FFF Enterprises or call 800-843-7477.

©2006 FFF Enterprises Inc.
Top of Page